The Not-So-New Challenges Of mRNA Delivery

Walter Straps, Ph.D., CEO of Carver Biosciences states that when it comes to mRNA, the challenges associated with its delivery are anything but new. Indeed, Straps explains that challenges have existed essentially since the dawn of nucleotide therapeutics in general. “There is a joke within the oligo nucleotide field similar to the real estate industry in that in real estate it’s location, location, location; for all nucleotides it's delivery, delivery, delivery,” says Straps.